Corticobasal Degeneration
Symptoms, Doctors, Treatments, Advances & More

Corticobasal Degeneration Overview

Save information for later
Sign Up

Learn About Corticobasal Degeneration

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Corticobasal Degeneration Local Doctors?
Elite in Corticobasal Degeneration
Elite in Corticobasal Degeneration

Johns Hopkins Outpatient Center

Baltimore, MD 
Languages Spoken:
English, Russian, Spanish, Ukrainian

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Elite provider by MediFind in the treatment of Corticobasal Degeneration. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Movement Disorders.

Elite in Corticobasal Degeneration
Elite in Corticobasal Degeneration

Memory And Aging Center

1651 Fourth St., Suite 212, 
San Francisco, CA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Salvatore Spina is a behavioral neurologist who cares for patients with degenerative, vascular, inflammatory and autoimmune conditions that cause problems with memory, thinking or language, or personality changes. This includes Alzheimer's disease, Parkinson's disease, Lewy body disease, frontotemporal dementia and various conditions that cause aphasia, which is loss of the ability to speak or to understand speech. He also treats patients with movement disorders accompanied by cognitive and behavioral symptoms, including those affected by corticobasal syndrome, progressive supranuclear palsy and motor neuron diseases. Spina's research investigates the relationship between cognitive changes and behavioral changes in patients with Alzheimer's disease, dementia, Parkinson's disease and other conditions that destroy the cells for such voluntary movements as walking, speaking and swallowing. He specifically examines inflammation in the brain, lost neurons and synapses, and brain changes that indicate disease progression. His study tools include evaluation of neurological symptoms, results from neuropsychological testing, neuroimaging with magnetic resonance imaging and positron emission tomography, and checking genetic or other kinds of biomarkers (measurable substances that can indicate disease). He is a member of the UCSF Neurodegenerative Disease Brain Bank, which uses donated nervous system tissue to further scientific understanding of these conditions. Spina earned his medical degree from the University of Catania. He completed a residency in neurology at the University of Siena, where he also earned a doctoral degree studying how neurodegenerative diseases arise when nerve cells lose their structure or function. He then completed a residency in neurology at Indiana University and a fellowship in behavioral neurology at UCSF. Spina is a member of the American Board of Psychiatry and Neurology, American Academy of Neurology and American Association of Neuropathologists. As a researcher, he has been honored by the European Confederation of Neuropathological Societies and Hellenic Society of Neuropathology. Dr. Spina is rated as an Elite provider by MediFind in the treatment of Corticobasal Degeneration. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Dementia, Corticobasal Degeneration, Alzheimer's Disease, and Frontotemporal Dementia. Dr. Spina is board certified in American Board Of Psychiatry And Neurology., Neurology. Dr. Spina is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Corticobasal Degeneration
Advanced in Corticobasal Degeneration

Aurora Neuroscience Innovation

2801 W Kinnickinnic River Pkwy, Ste 550, 
Milwaukee, WI 
Languages Spoken:
English
Offers Telehealth

Taylor Finseth is a Neurologist practicing medicine in Milwaukee, Wisconsin. Dr. Finseth is rated as an Advanced provider by MediFind in the treatment of Corticobasal Degeneration. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Camptocormism, Parkinson's Disease, Movement Disorders, and Conversion Disorder. Dr. Finseth is board certified in American Board Of Psychiatry & Neurology.

What are the latest Corticobasal Degeneration Clinical Trials?
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Background: Neurodegenerative disorders can lead to problems in movement or memory. Some can cause abnormal proteins to build up in brain cells. Researchers want to understand whether these diseases have related causes or risk factors.

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Swedish BioFINDER 2 Study

Summary: The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is used e.g. to characterize the role of beta-amyloid pathology in early diagnosis of Alzheimer's disease (AD) using amyloid-PET (18F-Flutemetamol) and Aβ analysis in cerebrospinal fluid samples. The BioFINDER 1 study has resulted in more than ...